Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Teruki Shimizu, Mako Tomogane, Masatsugu Miyashita, Osamu Ukimura & Eishi Ashihara. (2018) Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model. OncoImmunology 7:5.
Read now
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now
Read now
Articles from other publishers (46)
In Kang, Yumin Kim & Heung Kyu Lee. (2023) γδ T cells as a potential therapeutic agent for glioblastoma. Frontiers in Immunology 14.
Crossref
Crossref
Alexandra L. Morrison, Charlotte Sarfas, Laura Sibley, Jessica Williams, Adam Mabbutt, Mike J. Dennis, Steve Lawrence, Andrew D. White, Mark Bodman-Smith & Sally A. Sharpe. (2023) IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge. Vaccines 11:10, pages 1604.
Crossref
Crossref
Chun Zhang, Xiuxing Liu, Jing Xiao, Fanwen Jiang, Luzhong Fa, Hui Jiang, Lin Zhou, Wenru Su & Zhuping Xu. (2023) γδ T cells in autoimmune uveitis pathogenesis: A promising therapeutic target. Biochemical Pharmacology 213, pages 115629.
Crossref
Crossref
Roald Pfannes, Arkadiusz Pierzchalski, Ambra Maddalon, Alexandra Simion, Christos C. Zouboulis, Gerhard Behre, Ana Claudia Zenclussen, Sabine Westphal, Stefan Fest & Gunda Herberth. (2023) Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments. Frontiers in Immunology 14.
Crossref
Crossref
Jiamian Zheng, Dan Qiu, Xuan Jiang, Yun Zhao, Haotian Zhao, Xiaofang Wu, Jie Chen, Jing Lai, Wenbin Zhang, Xutong Li, Yangqiu Li, Xiuli Wu & Zhenyi Jin. (2022) Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemia. Frontiers in Oncology 12.
Crossref
Crossref
Yuan Song, Huey Yee Teo, Yonghao Liu, Xiaomeng Zhang, Jinmiao Chen, Yongliang Zhang & Haiyan Liu. (2022) Reviving human γδT cells from apoptosis induced by IL-12/18 via p-JNK inhibition. Journal of Leukocyte Biology 112:6, pages 1701-1716.
Crossref
Crossref
Kok Fei Chan, Jessica Da Gama Duarte, Simone Ostrouska & Andreas Behren. (2022) γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells. Frontiers in Immunology 13.
Crossref
Crossref
Lingling Ou, Huaishan Wang, Hui Huang, Zhiyan Zhou, Qiang Lin, Yeye Guo, Tara Mitchell, Alexander C. Huang, Giorgos Karakousis, Lynn Schuchter, Ravi Amaravadi, Wei Guo, Joseph Salvino, Meenhard Herlyn & Xiaowei Xu. (2022) Preclinical platforms to study therapeutic efficacy of human γδ T cells. Clinical and Translational Medicine 12:6.
Crossref
Crossref
Alessandro Allegra, Marco Casciaro, Elena Lo Presti, Caterina Musolino & Sebastiano Gangemi. (2022) Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy. Biomolecules 12:6, pages 754.
Crossref
Crossref
Maarten Versteven, Donovan Flumens, Diana Campillo-Davó, Hans De Reu, Laura Van Bruggen, Stefanie Peeters, Viggo Van Tendeloo, Zwi Berneman, Harry Dolstra, Sébastien Anguille, Willemijn Hobo, Evelien Smits & Eva Lion. (2022) Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands. Frontiers in Immunology 13.
Crossref
Crossref
Rama Rao Malla & Priyamvada Bhamidipati. (2022) γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer. Critical Reviews in Immunology 42:6, pages 9-15.
Crossref
Crossref
Diana Campillo-Davo, Sébastien Anguille & Eva Lion. (2021) Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia. Cancers 13:18, pages 4519.
Crossref
Crossref
Nilberto Dias de Araújo, Fábio Magalhães Gama, Mateus de Souza Barros, Thaís Lohana Pereira Ribeiro, Fabíola Silva Alves, Lilyane Amorim Xabregas, Andréa Monteiro Tarragô, Adriana Malheiro & Allyson Guimarães Costa. (2021) Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity. Journal of Immunology Research 2021, pages 1-15.
Crossref
Crossref
义 刘. (2021) Research Progress of Biological Characteristics and Anti-Tumor Immunotherapy of γδ T Cells. World Journal of Cancer Research 11:03, pages 83-90.
Crossref
Crossref
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot & Caroline Aspord. (2021) Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & Translational Immunology 10:11.
Crossref
Crossref
Adam Brufsky, Juan Luis Gomez Marti, Azadeh Nasrazadani & Michael T. Lotze. (2020) Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection. Journal of Translational Medicine 18:1.
Crossref
Crossref
Chirine Rafia, Christelle Harly & Emmanuel Scotet. (2020) Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors. Immunological Reviews 298:1, pages 117-133.
Crossref
Crossref
Yuxia Liu & Cai Zhang. (2020) The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy. Cells 9:5, pages 1206.
Crossref
Crossref
Pauline Girard, Benedicte Ponsard, Julie Charles, Laurence Chaperot & Caroline Aspord. (2020) Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints. Frontiers in Immunology 11.
Crossref
Crossref
Karin Schilbach, Christian Welker, Naomi Krickeberg, Carlotta Kaißer, Sabine Schleicher & Hisayoshi Hashimoto. (2020) In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells. Cancers 12:1, pages 130.
Crossref
Crossref
Sheng-chao Li, Zhuo Xu, Yan-li Deng, Ya-ni Wang & Yu-ming Jia. (2020) Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma. Medicine 99:27, pages e20919.
Crossref
Crossref
Sévérine de Bruijn, Sébastien Anguille, Joris Verlooy, Evelien L. Smits, Viggo F. van Tendeloo, Maxime de Laere, Koenraad Norga, Zwi N. Berneman & Eva Lion. (2019) Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer. Cancers 11:9, pages 1396.
Crossref
Crossref
Heleen H. Van Acker, Zoë P. Van Acker, Maarten Versteven, Peter Ponsaerts, Daniela Pende, Zwi N. Berneman, Sébastien Anguille, Viggo F. Van Tendeloo & Evelien L. Smits. (2019) CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15. Cancers 11:7, pages 1029.
Crossref
Crossref
Heleen H. Van Acker, Maarten Versteven, Felix S. Lichtenegger, Gils Roex, Diana Campillo-Davo, Eva Lion, Marion Subklewe, Viggo F. Van Tendeloo, Zwi N. Berneman & Sébastien Anguille. (2019) Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia. Journal of Clinical Medicine 8:5, pages 579.
Crossref
Crossref
Simon Milette, Pierre O Fiset, Logan A Walsh, Jonathan D Spicer & Daniela F Quail. (2019) The innate immune architecture of lung tumors and its implication in disease progression. The Journal of Pathology 247:5, pages 589-605.
Crossref
Crossref
Tsui Mao, Carol Miao, Yi Liao, Ying Chen, Chia Yeh & Chao Liu. (2019) Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth. International Journal of Molecular Sciences 20:5, pages 1139.
Crossref
Crossref
Yijing Zhao, Chao Niu & Jiuwei Cui. (2018) Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?. Journal of Translational Medicine 16:1.
Crossref
Crossref
Yijing Zhao, Chao Niu & Jiuwei Cui. (2018) Gamma-delta (γδ) T cells: friend or foe in cancer development?. Journal of Translational Medicine 16:1.
Crossref
Crossref
Heleen H. Van Acker, Diana Campillo-Davo, Gils Roex, Maarten Versteven, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Cytokine & Growth Factor Reviews 41, pages 54-64.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Hans De Reu, Zwi N. Berneman, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion. Frontiers in Immunology 9.
Crossref
Crossref
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Crossref
J.L. Weaver. 2018. Comprehensive Toxicology. Comprehensive Toxicology
717
731
.
Walter Gottlieb LandWalter Gottlieb Land. 2018. Damage-Associated Molecular Patterns in Human Diseases. Damage-Associated Molecular Patterns in Human Diseases
693
711
.
Heleen H. Van Acker, Anna Capsomidis, Evelien L. Smits & Viggo F. Van Tendeloo. (2017) CD56 in the Immune System: More Than a Marker for Cytotoxicity?. Frontiers in Immunology 8.
Crossref
Crossref
Tao Jiang, Xiao Chen, Wei Zhou, Guoxin Fan, Peilin Zhao, Shengxiang Ren, Caicun Zhou & Jun Zhang. (2017) Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer. Translational Oncology 10:2, pages 132-141.
Crossref
Crossref
Robin A. Nadar, Nicola Margiotta, Michele Iafisco, Jeroen J. J. P. van den Beucken, Otto C. Boerman & Sander C. G. Leeuwenburgh. (2017) Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer. Advanced Healthcare Materials 6:8, pages 1601119.
Crossref
Crossref
Heleen H. Van Acker, Ottavio Beretta, Sébastien Anguille, Lien De Caluwé, Angela Papagna, Johan M. Van den Bergh, Yannick Willemen, Herman Goossens, Zwi N. Berneman, Viggo F. Van Tendeloo, Evelien L. Smits, Maria Foti & Eva Lion. (2017) Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells. Oncotarget 8:8, pages 13652-13665.
Crossref
Crossref
Chang Zou, Pan Zhao, Zhangang Xiao, Xianghua Han, Fan Fu & Li Fu. (2016) γδ T cells in cancer immunotherapy. Oncotarget 8:5, pages 8900-8909.
Crossref
Crossref
Chao Niu, Haofan Jin, Min Li, Shan Zhu, Lei Zhou, Feng Jin, Yulai Zhou, Dongsheng Xu, Jianting Xu, Lianjing Zhao, Shanshan Hao, Wei Li & Jiuwei Cui. (2016) Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma. Oncotarget 8:4, pages 5954-5964.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits & Viggo F. Van Tendeloo. (2016) Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Sourav Paul & Girdhari Lal. (2016) Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer. International Journal of Cancer 139:5, pages 976-985.
Crossref
Crossref
Shiori Sugai, Toshiaki Yoshikawa, Tatsuaki Iwama, Nobuhiro Tsuchiya, Norihiro Ueda, Norihiro Fujinami, Manami Shimomura, Rong Zhang, Shin Kaneko, Yasushi Uemura & Tetsuya Nakatsura. (2016) Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate. International Journal of Oncology.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Evelien L. Smits & Viggo F. Van Tendeloo. (2016) Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials. Pharmacology & Therapeutics 158, pages 24-40.
Crossref
Crossref
Xuan Sun, Jian Suo & Jun Yan. (2016) Immunotherapy in human colorectal cancer: Challenges and prospective. World Journal of Gastroenterology 22:28, pages 6362.
Crossref
Crossref
Cheryl C. Collins, Kathleen Bashant, Cuixia Erikson, Phyu Myat Thwe, Karen A. Fortner, Hong Wang, Craig T. Morita & Ralph C. Budd. (2016) Necroptosis of Dendritic Cells Promotes Activation of γδ T Cells. Journal of Innate Immunity 8:5, pages 479-492.
Crossref
Crossref
Sébastien Anguille, Evelien L. Smits, Christian Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N. Hart, Viggo F. Van Tendeloo & Zwi N. Berneman. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews 67:4, pages 731-753.
Crossref
Crossref